Biovail must pay $25 million in criminal and civil fines after the company pled guilty to charges that it paid doctors thousands of dollars to prescribe it's blood pressure drug Cardizem LA. The New Jersey-based drugmaker will fork over $22.2 million for the charges and an additional $2.4 million civil penalty. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.
